White Paper
Driving adoption of digital tools in post-marketing safety studies: patients and investigators weigh in
Mar 17, 2021
Download

Post-marketing safety surveillance studies are becoming commonplace in Asia Pacific, especially in markets like China, South Korea, Japan and Philippines. The COVID-19 pandemic has presented a need for digital methods of safety data collection to complement traditional site-based data collection methods. While digital adoption is the much-awaited golden goose of the next generation of clinical studies, its uptake is hindered by practical challenges that need to be addressed at the user-end level rather than the technical or business requirement of a digital tool. To support the introduction of direct-to-patient solutions alongside physician data collection, this paper divulges key considerations in the design and process development or evaluation of digital tools to be used. Insights from a market research study including investigators and patients using a simulated solution are shared to support decision making on future digital tools.

This article was produced as part of the IQVIA APAC Insight magazine, to read the full publication please click here 

Contact Us